全新好(000007.SZ):控股股東一致行動人之一劉紅所持160萬股因誤操作在一致行動協議之補充協議到期前已全部賣出
格隆匯5月25日丨全新好(000007.SZ)公佈,2020年5月25日公司收到控股股東一致行動人之一劉紅郵寄送達的《告知函》。函件告知公司劉紅持有公司的160萬股股票因誤操作在《一致行動協議之補充協議》到期前已全部賣出。
此次減持前,劉紅持有公司股票160萬股,佔公司總股本的0.46%。此次減持後劉紅不再持有公司股票。劉紅減持後不再持有公司股份,截止2020年5月25日剩餘六位一致行動人博恆投資、陳卓婷、李強、陸爾東、林昌珍、陳軍合計持有公司股份約7751.38萬股,佔總股本的22.37%,合計仍為公司第一大股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.